-
1
-
-
0017042882
-
Design and analysis of randomized clinical trials requiring prolonged observation of each patient
-
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer. 1976;34:585-612.
-
(1976)
Br J Cancer
, vol.34
, pp. 585-612
-
-
Peto, R.1
Pike, M.C.2
Armitage, P.3
Breslow, N.E.4
Cox, D.R.5
Howard, S.V.6
Mantel, N.7
McPherson, K.8
Peto, J.9
Smith, P.G.10
-
2
-
-
0345006938
-
The analysis of data from clinical trials
-
Armitage P. The analysis of data from clinical trials. Statistician. 1979;179-183.
-
(1979)
Statistician
, pp. 179-183
-
-
Armitage, P.1
-
3
-
-
0003349279
-
Exclusions, losses to follow-up, and withdrawals in clinical trials
-
Shapiro SH and Louis TA, ed. New York, NY: Marcel Dekker, Inc.
-
Armitage P. Exclusions, losses to follow-up, and withdrawals in clinical trials. In: Shapiro SH and Louis TA, ed. Clinical Trials. New York, NY: Marcel Dekker, Inc.; 1983:99-113.
-
(1983)
Clinical Trials
, pp. 99-113
-
-
Armitage, P.1
-
4
-
-
0021818101
-
Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials
-
Gail MH. Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials. Cancer Treat Rep. 1985;69:1107-1113.
-
(1985)
Cancer Treat Rep
, vol.69
, pp. 1107-1113
-
-
Gail, M.H.1
-
5
-
-
0000368172
-
Intention to treat in clinical trials
-
Peace KE, ed. New York, NY: Marcel Dekker, Inc.
-
Fisher LD, Dixon LO, Herson J, Frankowski RK, Hearron MS, Peace KE. Intention to treat in clinical trials. In: Peace KE, ed. Statistical issues in Drug Research and Development. New York, NY: Marcel Dekker, Inc.; 1990.
-
(1990)
Statistical Issues in Drug Research and Development
-
-
Fisher, L.D.1
Dixon, L.O.2
Herson, J.3
Frankowski, R.K.4
Hearron, M.S.5
Peace, K.E.6
-
6
-
-
0032537894
-
International Conference on Harmonisation; Guidance on statistical principles for clinical trials
-
International Conference on Harmonisation; Guidance on statistical principles for clinical trials. Federal Register. 1998;69:49583-49598.
-
(1998)
Federal Register
, vol.69
, pp. 49583-49598
-
-
-
7
-
-
0034043860
-
The International Conference on Harmonisation guideline "Statistical Principles for Clinical Trials": Issues in applying the guideline in practice
-
Phillips A, Ebbutt A, France L, Morgan D. The International Conference on Harmonisation guideline "Statistical Principles for Clinical Trials": Issues in applying the guideline in practice. Drug Inf J. 2000;34:337-348.
-
(2000)
Drug Inf J
, vol.34
, pp. 337-348
-
-
Phillips, A.1
Ebbutt, A.2
France, L.3
Morgan, D.4
-
8
-
-
58149417330
-
Estimating causal effects of treatments in randomized and nonrandomized studies
-
Rubin DB. Estimating causal effects of treatments in randomized and nonrandomized studies. J Education Psychol. 1974;66:688-701.
-
(1974)
J Education Psychol
, vol.66
, pp. 688-701
-
-
Rubin, D.B.1
-
9
-
-
0002531157
-
Bayesian inference for causal effects: The role of randomization
-
Rubin DB. Bayesian inference for causal effects: the role of randomization. Ann Stat. 1978;6:34-58.
-
(1978)
Ann Stat
, vol.6
, pp. 34-58
-
-
Rubin, D.B.1
-
10
-
-
0032372107
-
Why permutation tests are superior to t and F tests in biomedical research
-
Ludbrook J, Dudley H. Why permutation tests are superior to t and F tests in biomedical research. Am Statistician. 1998;52:127-132.
-
(1998)
Am Statistician
, vol.52
, pp. 127-132
-
-
Ludbrook, J.1
Dudley, H.2
-
11
-
-
0036402786
-
Groundhog day: Cause and effect and the primary importance of the finite population induced by randomization
-
Stewart WH. Groundhog day: cause and effect and the primary importance of the finite population induced by randomization. J Biopharmaceutical Stat. 2002;12:93-105.
-
(2002)
J Biopharmaceutical Stat
, vol.12
, pp. 93-105
-
-
Stewart, W.H.1
|